-
公开(公告)号：US20230357233A1
公开(公告)日：2023-11-09
申请号：US18042872
申请日：2021-08-26
发明人： Xing DAI , Hong YANG , Xianhai HUANG , Haotao NIU , Zixing HAN , Zhenwu WANG , Qiang ZHANG , Yanqin LIU , Yueheng JIANG , Liangshan TAO , Jifang WENG , Zhe SHI , Yaolin WANG
IPC分类号： C07D471/04 , A61K45/06 , C07D519/00
CPC分类号： C07D471/04 , A61K45/06 , C07D519/00
摘要： Provided herein are novel compounds, for example, compounds having a Formula (I), Formula (A), Formula (II), Formula (III), Formula (IV), or Formula (V), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRASG12D in a cancer cell, and/or in treating various cancer such as pancreatic cancer, colorectal cancer, lung cancer (e.g., non-small cell lung cancer) or endometrial cancer.
-
公开(公告)号：US20210355125A1
公开(公告)日：2021-11-18
申请号：US17365503
申请日：2021-07-01
发明人： Xing DAI , Yaolin WANG , Yueheng JIANG , Yanqin LIU , Zhe SHI , Zhenwu WANG , Liangshan TAO , Zixing HAN , Haotao NIU , Jifang WENG
IPC分类号： C07D471/04 , A61P35/00 , A61K33/243 , A61K31/282 , A61K31/438 , A61K31/519 , C07D519/00
摘要： Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).
-
公开(公告)号：US20230357260A1
公开(公告)日：2023-11-09
申请号：US18316471
申请日：2023-05-12
发明人： Xing DAI , Yaolin WANG , Yueheng JIANG , Yanqin LIU , Haotao NIU , Zhenwu WANG , Zixing HAN , Liangshan TAO , Jifang WENG , Zhe SHI
IPC分类号： C07D493/08 , C07D401/14 , C07D405/14 , C07D417/14 , C07D487/04
CPC分类号： C07D493/08 , C07D401/14 , C07D405/14 , C07D417/14 , C07D487/04
摘要： Provided herein are novel heterocyclic compounds, for example, compounds having Formula I. Also provided herein are methods of preparing the compounds and methods of using the same, for example, in inhibiting TGF-beta mediated signaling and/or for treating cancer.
-
公开(公告)号：US20210355110A1
公开(公告)日：2021-11-18
申请号：US17284149
申请日：2019-10-11
发明人： Dai XING , Yaolin WANG , Yueheng JIANG , Yanqin LIU , Zixing HAN , Zhenwu WANG , Liangshan TAO , Zhe SHI
IPC分类号： C07D403/12 , C07D405/14 , C07D401/14 , C07F9/6509 , C07D403/14 , C07D413/14 , C07D471/04 , C07D403/10
摘要： Provided herein are novel thyroid hormone receptor (TR) agonists e.g., having Formula I, II, or III. Also provided are methods of preparing the novel TR agonists and method of using the novel TR agonists for treating diseases or disorder modulated by TR agonists, such as NAFLD, NASH, diabetes, hyperlipidemia and/or hypercholesterolemia.
-
公开(公告)号：US20230242544A1
公开(公告)日：2023-08-03
申请号：US18011138
申请日：2021-06-30
发明人： Xing DAI , Yaolin WANG , Yueheng JIANG , Haotao NIU , Yanqin LIU , Hong YANG , Zixing HAN , Zhenwu WANG , Liangshan TAO , Qiang ZHANG , Zhe SHI , Jifang WENG
IPC分类号： C07D487/08 , C07D403/12 , C07D403/14 , C07D487/04 , C07D487/10 , C07D519/00 , C07D417/14 , A61K45/06
CPC分类号： C07D487/08 , C07D403/12 , C07D403/14 , C07D487/04 , C07D487/10 , C07D519/00 , C07D417/14 , A61K45/06
摘要： Provided herein are novel compounds, for example, compounds having a Formula (I), Formula (II), or Formula (III), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRASG12D in a cancer cell, and/or in treating various cancer such as pancreatic cancer, colorectal cancer, lung cancer or endometrial cancer.
-
公开(公告)号：US20210198255A1
公开(公告)日：2021-07-01
申请号：US17172988
申请日：2021-02-10
发明人： Xing DAI , Yaolin WANG , Yueheng JIANG , Yanqin LIU , Zhe SHI , Zhenwu WANG , Liangshan TAO , Zixing HAN , Haotao NIU , Jifang WENG
IPC分类号： C07D471/04 , C07D519/00 , A61P35/00 , A61K31/282 , A61K33/243 , A61K31/438 , A61K31/519
摘要： Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.014 秒)
